Effectiveness and tolerability of intravenous fosfomycin in treating complicated urinary tract infections caused by Escherichia coli: a prospective cohort study from the FOSFOMIC project.

Moreno-Mellado E, Aslan AT, Akova M, León E, Merchante N, Vinuesa D, Moral-Escudero E, Sadyrbaeva-Dolgova S, López-Cárdenas S, Cano-Yuste Á, Rinaldi M, Núñez-Núñez M, Giannella M, Sojo-Dorado J, Antolí-Royo AC, Chacón N, Merino-Bohórquez V, Portillo I, Rodríguez-Baño J, Docobo-Pérez F, Gutiérrez-Gutiérrez B, FOSFOMIC team

Open source

DOI
10.1016/j.cmi.2025.01.007
Published
2025 May
Container
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.cmi.2025.01.007,
  title = {Effectiveness and tolerability of intravenous fosfomycin in treating complicated urinary tract infections caused by Escherichia coli: a prospective cohort study from the FOSFOMIC project.},
  author = {Moreno-Mellado E and Aslan AT and Akova M and León E and Merchante N and Vinuesa D and Moral-Escudero E and Sadyrbaeva-Dolgova S and López-Cárdenas S and Cano-Yuste Á and Rinaldi M and Núñez-Núñez M and Giannella M and Sojo-Dorado J and Antolí-Royo AC and Chacón N and Merino-Bohórquez V and Portillo I and Rodríguez-Baño J and Docobo-Pérez F and Gutiérrez-Gutiérrez B and FOSFOMIC team},
  year = {2025},
  journal = {Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases},
  doi = {10.1016/j.cmi.2025.01.007},
  url = {https://doi.org/10.1016/j.cmi.2025.01.007}
}

RIS

TY  - JOUR
TI  - Effectiveness and tolerability of intravenous fosfomycin in treating complicated urinary tract infections caused by Escherichia coli: a prospective cohort study from the FOSFOMIC project.
AU  - Moreno-Mellado E
AU  - Aslan AT
AU  - Akova M
AU  - León E
AU  - Merchante N
AU  - Vinuesa D
AU  - Moral-Escudero E
AU  - Sadyrbaeva-Dolgova S
AU  - López-Cárdenas S
AU  - Cano-Yuste Á
AU  - Rinaldi M
AU  - Núñez-Núñez M
AU  - Giannella M
AU  - Sojo-Dorado J
AU  - Antolí-Royo AC
AU  - Chacón N
AU  - Merino-Bohórquez V
AU  - Portillo I
AU  - Rodríguez-Baño J
AU  - Docobo-Pérez F
AU  - Gutiérrez-Gutiérrez B
AU  - FOSFOMIC team
PY  - 2025
JO  - Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
DO  - 10.1016/j.cmi.2025.01.007
UR  - https://doi.org/10.1016/j.cmi.2025.01.007
ER  - 

APA

E, M., AT, A., M, A., E, L., N, M., D, V., E, M., S, S., S, L., Á, C., M, R., M, N., M, G., J, S., AC, A., N, C., V, M., I, P., J, R., F, D., B, G., & team, F. (2025). Effectiveness and tolerability of intravenous fosfomycin in treating complicated urinary tract infections caused by Escherichia coli: a prospective cohort study from the FOSFOMIC project.. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. https://doi.org/10.1016/j.cmi.2025.01.007

Source records